Literature DB >> 8099420

Prolonged QT interval with halofantrine.

E Monlun, O Pillet, J F Cochard, J C Favarel Garrigues, M le Bras.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099420

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

1.  Potentiation of halofantrine-induced QTc prolongation by mefloquine: correlation with blood concentrations of halofantrine.

Authors:  I D Lightbown; J P Lambert; G Edwards; S J Coker
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Drug-induced changes in the T-wave morphology.

Authors:  Marek Malik
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

Review 3.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 4.  Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling.

Authors:  M Malik; A J Camm
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

5.  Stereoselective halofantrine disposition and effect: concentration-related QTc prolongation.

Authors:  D R Abernethy; D L Wesche; J T Barbey; C Ohrt; S Mohanty; J C Pezzullo; B G Schuster
Journal:  Br J Clin Pharmacol       Date:  2001-03       Impact factor: 4.335

6.  Inhibition of HERG potassium channels by the antimalarial agent halofantrine.

Authors:  H Tie; B D Walker; C B Singleton; S M Valenzuela; J A Bursill; K R Wyse; S N Breit; T J Campbell
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

Review 7.  New antimalarials. A risk-benefit analysis.

Authors:  F Nosten; R N Price
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 8.  Adverse effects of chemotherapeutic agents used in tropical medicine.

Authors:  G C Cook
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

Review 9.  Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 10.  Fatal cardiotoxicity related to halofantrine: a review based on a worldwide safety data base.

Authors:  Olivier Bouchaud; Patrick Imbert; Jean Etienne Touze; Alex N O Dodoo; Martin Danis; Fabrice Legros
Journal:  Malar J       Date:  2009-12-10       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.